Abstract
Purpose
To assess the safety and effectiveness of treating corneal endothelial rejection with a subconjunctival injection of 20 mg triamcinolone acetonide in combination with topical application of 1% prednisolone acetate, as compared to treatment with an intravenous pulse of 500 mg methylprednisolone in combination with topical application of 1% prednisolone acetate.
Methods
A case–controlled study including a literature review was performed. Patients who presented with an initial episode of corneal endothelial rejection were treated with subconjunctival injection of 20 mg triamcinolone in combination with topically applied 1% prednisolone and were retrospectively matched for age and diagnosis to patients who received a single intravenous injection of 500 mg methylprednisolone in combination with topical 1% prednisolone. Patients were analysed regarding reversion of the rejection episode, intraocular pressure, and visual acuity after 1 year.
Results
Overall, the triamcinolone group had a better outcome regarding reversion of corneal transplant rejection (P=0.025), with 15 of 16 patients in the triamcinolone group having clear grafts, compared to only 10 of 16 patients in the methylprednisolone group. Intraocular pressure (IOP) was increased in both groups at day 30 (P=0.002), although there was no statistically significant difference in IOP between the groups (P=0.433). Visual acuity improved in both groups after 1 year (P=0.049), although slightly more improvement was observed in the triamcinolone group (P=0.002).
Conclusions
The results observed in this case–controlled study suggest that the use of subconjunctival triamcinolone acetonide may benefit patients with corneal transplant rejection.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Williams KA, Muehlberg SM, Lewis RF, Coster DJ . Long-term outcome in corneal allotransplantation. The Australian Corneal Graft Registry. Transplant Proc 1997; 29 (1–2): 983.
Price MO, Thompson Jr RW, Price Jr FW . Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol 2003; 121 (8): 1087–1092.
Thompson Jr RW, Price MO, Bowers PJ, Price Jr FW . Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003; 110 (7): 1396–1402.
Williams KA, Esterman AJ, Bartlett C, Holland H, Hornsby NB, Coster DJ . How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 2006; 81 (6): 896–901.
Sit M, Weisbrod DJ, Naor J, Slomovic AR . Corneal graft outcome study. Cornea 2001; 20 (2): 129–133.
Hill JC, Maske R, Watson P . Corticosteroids in corneal graft rejection. Oral vs single pulse therapy. Ophthalmology 1991; 98 (3): 329–333.
Hill JC, Ivey A . Corticosteroids in corneal graft rejection: double vs single pulse therapy. Cornea 1994; 13 (5): 383–388.
Young AL, Rao SK, Cheng LL, Wong AK, Leung AT, Lam DS . Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience. Eye 2002; 16 (3): 304–308.
Hudde T, Minassian DC, Larkin DF . Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection. Br J Ophthalmol 1999; 83 (12): 1348–1352.
Alldredge OC, Krachmer JH . Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 1981; 99 (4): 599–604.
The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 1992; 110 (10): 1392–1403.
Naacke HG, Borderie VM, Bourcier T, Touzeau O, Moldovan M, Laroche L . Outcome of Corneal transplantation rejection. Cornea 2001; 20 (4): 350–353.
Boisjoly HM, Tourigny R, Bazin R, Laughrea PA, Dubé I, Chamberland G et al. Risk factors of corneal graft failure. Ophthalmology 1993; 100 (11): 1728–1735.
Panda A, Vanathi M, Kumar A, Dash Y, Priya S . Corneal graft rejection. Surv Ophthalmol 2007; 52 (4): 375–396.
Coster DJ, Williams KA . The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 2005; 140 (6): 1112–1122.
Barker NH, Henderson TR, Ross CA, Coster DJ, Williams KA . Current Australian practice in the prevention and management of corneal allograft rejection. Clin Experiment Ophthalmol 2000; 28 (5): 357–360.
Koay PY, Lee WH, Figueiredo FC . Opinions on risk factors and management of corneal graft rejection in the United Kingdom. Cornea 2005; 24 (3): 292–296.
Randleman JB, Stulting RD . Prevention and treatment of corneal graft rejection: current practice patterns (2004). Cornea 2006; 25 (3): 286–290.
Rinne JR, Stulting RD . Current practices in the prevention and treatment of corneal graft rejection. Cornea 1992; 11 (4): 326–328.
Thiel MA, Ross CA, Coster DJ . Corneal allograft rejection: has the time come for intravenous pulsed methylprednisolone? A debate. Clin Experiment Ophthalmol 2000; 28 (6): 398–404.
Inoue K, Amano S, Kimura C, Sato T, Fujita N, Kagaya F et al. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Jpn J Ophthalmol 2000; 44 (3): 302–305.
Lam DS, Wong AK, Tham CC, Leung AT . The use of combined intravenous pulse methylprednisolone and oral cyclosporin A in the treatment of corneal graft rejection: a preliminary study. Eye 1998; 12 ( Pt 4): 615–618.
Moro F, Cvintal T . Tratamento Padrão da Rejeição. In: Cvintal T (ed). Complicações do Transplante de Córnea. Livraria Santos Editora Ltda.: São Paulo, 2004, pp 241–245.
Ehlers JP, Shah CP, Fenton GL, Hoskins EN, Shelsta HN . The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease, 5th edn. Lippincott Williams & Wilkins: Philadelphia, 2008, pp 97–98.
Bandello F, Pognuz R, Polito A, Pirracchio A, Menchini F, Ambesi M . Diabetic macular edema: classification, medical and laser therapy. Semin Ophthalmol 2003; 18 (4): 251–258.
Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE . Macular edema. Surv Ophthalmol 2004; 49 (5): 470–490.
Ip MS . Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema. Diabetes Care 2004; 27 (7): 1794–1797.
Jonas JB . Intravitreal triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol 2007; 39: 96–110.
Gulkilik G, Demirci G, Ozdamar AM, Muftuoglu GI . A case of herpetic keratitis after intravitreal triamcinolone injection. Cornea 2007; 26 (8): 1000–1001.
Shtein RM, Stahl RM, Saxe SJ, Mian SI . Herpes simplex keratitis after intravitreal triamcinolone acetonide. Cornea 2007; 26 (5): 641–642.
Weijtens O, Feron EJ, Schoemaker RC, Cohen AF, Lentjes EG, Romijn FP et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 1999; 128 (2): 192–197.
Jonas JB . Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 2004; 137 (3): 560–562.
Thomas ER, Wang J, Ege E, Madsen R, Hainsworth DP . Intravitreal triamcinolone acetonide concentration after subtenon injection. Am J Ophthalmol 2006; 142 (5): 860–861.
Epstein AJ, de Castro TN, Laibson PR, Cohen EJ, Rapuano CJ . Risk factors for the first episode of corneal graft rejection in keratoconus. Cornea 2006; 25 (9): 1005–1011.
Roth DB, Realini T, Feuer WJ, Radhakrishnan R, Gloth J, Heimmel MR et al. Short-term complications of intravitreal injection of triamcinolone acetonide. Retina 2008; 28 (1): 66–70.
Yamamoto Y, Komatsu T, Koura Y, Nishino K, Fukushima A, Ueno H . Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection. Can J Ophthalmol 2008; 43 (1): 42–47.
Author information
Authors and Affiliations
Corresponding author
Additional information
Accepted for presentation at ARVO 2008 annual meeting
Rights and permissions
About this article
Cite this article
Costa, D., de Castro, R. & Kara-Jose, N. Case–control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection. Eye 23, 708–714 (2009). https://doi.org/10.1038/eye.2008.289
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2008.289
Keywords
This article is cited by
-
Methylprednisolone/prednisolone acetate/triamcinolone
Reactions Weekly (2018)
-
Reply to: Costa DC et al
Eye (2009)
